Clinical Trials Browser

Phase 2 × Papillomavirus Infections × Adjuvants, Pharmaceutic × Clear all

NCT00693615 2016-09-16

Safety and Immunogenicity Study of MEDI-517 (GSK 580299) With or Without Adjuvant in Healthy Adult Females

Phase 2 Completed

Papillomavirus Infections